


| Key | % Net Assets |
|---|---|
| 5.7% | |
| 5.6% | |
| 4.4% | |
| 3.8% | |
| 80.5% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 5.7% |
| Royal Dutch Shell | 5.6% |
| Vodafone | 4.4% |
| British American Tobacco | 3.8% |
| Unilever | 2.9% |
| AstraZeneca | 2.8% |
| BT Group | 2.7% |
| Imperial Tobacco | 2.7% |
| HSBC Holdings | 2.5% |
| Centrica | 1.9% |
No asset data available.
| Date | 19-Aug-2024 |
|---|---|
| NAV | 345.50p |
| Currency | GBP |
| Change | 0.20p |
| % | 0.06% |
| YTD change | 345.50p |
| YTD % | n/a |
| Fund Inception | 18/10/2004 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research